Type 2 diabetes mellitus (T2DM) and obesity represent two of the biggest global health
challenges of this century and are associated with significant comorbidities and healthcare …

Gut microbiota is involved in the development of several chronic diseases, including
diabetes, obesity, and cancer, through its interactions with the host organs. It has been …

It has become apparent that gut microbiota is closely associated with cardiometabolic
diseases (CMDs), and alteration in microbiome compositions is also linked to the host …

In recent years, mounting scientific evidence has emerged regarding the evaluation of the
putative correlation between the gut microbiota composition and the presence of chronic …

Trimethylamine N-oxide (TMAO) is a biologically active gut microbiome-derived dietary
metabolite. Recent studies have shown that high circulating plasma TMAO levels are closely …

In the United States, there are persistent and widening socioeconomic gaps in morbidity and
mortality from chronic diseases. Although most disparities research focuses on person-level …

Gut dysbiosis may result in various diseases, such as metabolic and neurobehavioral
disorders. Exposure to endocrine disrupting chemicals (EDCs), including bisphenol A (BPA) …

Gut microbiota have recently been suggested to play a part in low-grade systemic
inflammation, which is considered a key risk factor for cardiometabolic disorders. Diet is …

Objective The objective of this review was to critically review findings from recent studies
evaluating the effects of nonnutritive sweeteners (NNSs) on metabolism, weight, and obesity …

Purpose Based on the fermentable oligosaccharides, disaccharides, monosaccharides and
polyols (FODMAP) hypothesis, the low-FODMAP diet has been suggested as a potential …